Related Experiment Video
Updated: Feb 24, 2026

13:34
Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
12.0K
Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants
Pulkit Gupta1, Zhifen Zhang2,3, Seiji N Sugiman-Marangos2
1From Merck & Co., Inc., Kenilworth, New Jersey 07033.
The Journal of Biological Chemistry
|August 27, 2017
Summary
Researchers identified the CSPG4 binding site on Clostridium difficile toxin B (TcdB), revealing the combined repetitive oligopeptide (CROP) domain
Area of Science:
- Microbiology
- Cell Biology
- Toxicology
Background:
- Clostridium difficile produces toxins TcdA and TcdB, crucial for disease.
- TcdB is a primary cause of C. difficile-related human illness.
- TcdB utilizes host cell receptors for entry, with CSPG4, NECTIN3, and FZD1/2/7 identified.
Purpose of the Study:
- To identify specific binding sites of TcdB on host cell receptors.
- To investigate the role of the combined repetitive oligopeptide (CROP) domain in TcdB receptor binding.
- To understand the mechanism of TcdB-mediated cell intoxication.
Main Methods:
- Screening TcdB for essential intoxication sites.
- Utilizing C-terminal truncations to map binding regions.
- Testing TcdB binding and toxicity on CSPG4-expressing cells.
- Assessing the impact of anti-TcdB antibody bezlotoxumab on CSPG4 binding.
Main Results:
- A region at the translocation and CROP domain junction is implicated in CSPG4 binding.
- The CSPG4 binding site extends into the CROP domain, requiring three short repeats.
- Bezlotoxumab binding partially overlaps the CSPG4 binding site, inhibiting binding.
- The CROP domain plays a role in TcdB receptor binding.
Conclusions:
- The CSPG4 binding site on TcdB has been localized to the translocation-CROP domain junction and within the CROP domain.
- This study demonstrates a novel role for the TcdB CROP domain in host cell receptor binding.
- Findings clarify TcdB pathogenesis and provide insights for therapeutic strategies targeting TcdB-host interactions.

